Tue, September 18, 2018
Mon, September 17, 2018
Fri, September 14, 2018
Thu, September 13, 2018
Wed, September 12, 2018
Tue, September 11, 2018
Mon, September 10, 2018
Fri, September 7, 2018
Thu, September 6, 2018
Wed, September 5, 2018
Tue, September 4, 2018
Fri, August 31, 2018
Thu, August 30, 2018
Wed, August 29, 2018
Tue, August 28, 2018
Mon, August 27, 2018
Fri, August 24, 2018
Thu, August 23, 2018

Keay Nakae Maintained (ARWR) at Strong Buy with Increased Target to $25 on, Sep 6th, 2018


//stocks-investing.news-articles.net/content/201 .. with-increased-target-to-25-on-sep-6th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Keay Nakae of Chardan Capital, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Increased Target from $18 to $25 on, Sep 6th, 2018.

Keay has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Keay's Rating of Hold.



This is the rating of the analyst that currently disagrees with Keay


  • Elemer Piros of "Cantor Fitzgerald" Upgraded from Hold to Buy on, Wednesday, May 9th, 2018

Publication Contributing Sources